UVSP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Buy now. UVSP is coming off a strong Q4 2025 earnings print (double-digit revenue growth and ~20%+ net income/EPS growth) plus a maintained dividend, while the chart still shows a bullish longer-trend moving-average structure. Near-term momentum is mixed (bearish MACD), but price is sitting close to support, making the current level acceptable for an impatient buyer looking for a reasonably timed entry rather than waiting for a perfect setup.
Intellectia Proprietary Trading Signals
Trend/structure is still constructive: moving averages are bullishly stacked (SMA_5 > SMA_20 > SMA_200), suggesting the broader trend remains up. However, momentum is softening: MACD histogram is negative (-0.0685) and expanding bearishly, implying downside pressure in the very near term. RSI_6 at 45.4 is neutral (no oversold bounce signal).
Key levels: price ~33.16 is below the pivot (33.767), with nearby support at S1=32.686 (then S2=32.019). Upside resistance is R1=34.849 (then R2=35.516). A practical read is "buy near support" with the market needing to reclaim ~33.77 to improve near-term momentum; otherwise, a dip toward ~32.69 is plausible before strength returns.
Q4 2025 results were strong: revenue +9.6% YoY, net income +20.1% YoY, EPS +23.1% YoY; company highlighted record annual EPS ($3.13). Dividend declared at $0.22/share supports shareholder-return narrative. News flow is clearly positive and earnings-driven (event catalyst just occurred).
Near-term technical momentum is weakening (bearish/expanding MACD histogram) and price is below the pivot (~33.77), so a short-term pullback toward ~32.69 support is possible. Options are illiquid, limiting sentiment confirmation. Hedge fund and insider trends are neutral (no strong sponsorship signal).
Latest quarter (2025/Q4): Revenue $77.23M (+9.60% YoY), Net Income $22.745M (+20.08% YoY), EPS $0.80 (+23.08% YoY). Overall pattern: accelerating profitability relative to revenue (earnings growing faster than sales), which is a favorable growth trend for a regional bank coming out of the quarter.
Recent coverage update: 2025-12-03 Piper Sandler initiated at Neutral with a $34 price target. Street view based on this datapoint is balanced: pros are improving earnings and steady dividend; cons are limited upside to the $34 area from ~$33.16 (modest near-term upside) and no clear wave of bullish upgrades shown in the provided data. Overall, Wall Street tone in the dataset skews "wait-and-see," but fundamentals argue the stock can still be bought for a steady, dividend-supported rebound toward resistance.
